Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of
Journal
Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
entrez:
13
9
2021
pubmed:
14
9
2021
medline:
3
11
2021
Statut:
ppublish
Résumé
The clinical efficacy of epidermal growth factor receptor (EGFR)–targeted therapy in
Identifiants
pubmed: 34516823
doi: 10.1126/scitranslmed.abb3738
pmc: PMC8627689
mid: NIHMS1758040
doi:
Substances chimiques
Protein Kinase Inhibitors
0
EGFR protein, human
EC 2.7.10.1
ErbB Receptors
EC 2.7.10.1
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
eabb3738Subventions
Organisme : NCI NIH HHS
ID : F31 CA192623
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA222823
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA220497
Pays : United States
Organisme : NLM NIH HHS
ID : T15 LM007092
Pays : United States
Références
Clin Cancer Res. 2009 Dec 15;15(24):7502-7509
pubmed: 20008850
Sci Transl Med. 2010 Jan 27;2(16):16ra7
pubmed: 20371474
Cancer Discov. 2019 Jul;9(7):926-943
pubmed: 31092401
Clin Cancer Res. 2013 Apr 15;19(8):2240-7
pubmed: 23470965
Nat Med. 2013 Nov;19(11):1389-400
pubmed: 24202392
J Mol Biol. 2001 Aug 31;311(5):1011-26
pubmed: 11531336
Hematol Oncol Clin North Am. 2017 Aug;31(4):589-612
pubmed: 28673390
Lancet Oncol. 2020 Mar;21(3):373-386
pubmed: 32027846
Mol Oncol. 2014 Sep 12;8(6):1084-94
pubmed: 24913799
Clin Cancer Res. 2014 Mar 15;20(6):1698-1705
pubmed: 24429876
Lung Cancer. 2016 Aug;98:59-61
pubmed: 27393507
J Clin Oncol. 2018 Nov 1;36(31):3101-3109
pubmed: 30156984
N Engl J Med. 2009 Sep 3;361(10):947-57
pubmed: 19692680
Ann Oncol. 2015 Oct;26(10):2073-8
pubmed: 26269204
Cancer Biol Ther. 2019;20(9):1183-1186
pubmed: 31131689
Cancer Discov. 2016 Dec;6(12):1334-1341
pubmed: 27694386
Nature. 2012 Jul 26;487(7408):500-4
pubmed: 22763439
Respir Med Case Rep. 2017 Feb 17;20:160-163
pubmed: 28271038
Clin Cancer Res. 2019 Aug 15;25(16):4966-4972
pubmed: 30988082
Lancet Respir Med. 2020 Nov;8(11):1132-1143
pubmed: 32479794
J Thorac Oncol. 2016 Aug;11(8):1293-1304
pubmed: 27262212
Cell Rep. 2015 Feb 24;10(7):1187-201
pubmed: 25704820
N Engl J Med. 2020 Sep 3;383(10):944-957
pubmed: 32877583
Int Rev Cell Mol Biol. 2015;320:41-73
pubmed: 26614871
Nat Rev Mol Cell Biol. 2006 Jul;7(7):505-16
pubmed: 16829981
J Thorac Oncol. 2016 May;11(5):737-747
pubmed: 26899759
J Clin Oncol. 2013 Sep 20;31(27):3327-34
pubmed: 23816960
PLoS One. 2011;6(9):e24739
pubmed: 21931838
Arch Pathol Lab Med. 2014 Feb;138(2):241-56
pubmed: 24099077
N Engl J Med. 2020 Jan 2;382(1):41-50
pubmed: 31751012
Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12039-44
pubmed: 14528000
Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20932-7
pubmed: 18093943
Ann Oncol. 2020 Dec;31(12):1693-1703
pubmed: 32916265
Science. 2004 Jun 4;304(5676):1497-500
pubmed: 15118125
Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):E2836-E2845
pubmed: 28320942
JCI Insight. 2016 Nov 17;1(19):e87062
pubmed: 27882345
Clin Cancer Res. 2008 May 15;14(10):2895-9
pubmed: 18483355
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5021-6
pubmed: 21385943
Cancer Cell. 2020 Jan 13;37(1):104-122.e12
pubmed: 31935369
Clin Cancer Res. 2018 Dec 1;24(23):5963-5976
pubmed: 30072474
Mol Cancer Res. 2019 Jan;17(1):212-224
pubmed: 30171175
Sci Transl Med. 2011 Mar 23;3(75):75ra26
pubmed: 21430269
Cancer Cell. 2010 Jan 19;17(1):77-88
pubmed: 20129249
Nucleic Acids Res. 2020 Jul 2;48(W1):W488-W493
pubmed: 32246720
Nat Commun. 2015 Mar 11;6:6377
pubmed: 25758528
Science. 2007 May 18;316(5827):1039-43
pubmed: 17463250
N Engl J Med. 2004 May 20;350(21):2129-39
pubmed: 15118073
Clin Cancer Res. 2013 Apr 1;19(7):1773-83
pubmed: 23307858
Clin Cancer Res. 2020 May 15;26(10):2393-2403
pubmed: 32034078
PLoS Comput Biol. 2019 May 20;15(5):e1006752
pubmed: 31107860